Agenda of the HMPC meeting 22-24 September 2026
Submitted by Anonymous (not verified) on 22 September 2026 - 13:00
Agenda of the HMPC meeting 22-24 September 2026
Records of data processing activity Industry Single Point of Contact (i-SPOC) reporting system
Submitted by Anonymous (not verified) on 22 September 2026 - 12:45
Records of data processing activity Industry Single Point of Contact (i-SPOC) reporting system
European Medicines Agency’s privacy statement for the Industry Single Point of Contact (i-SPOC) system
Submitted by Anonymous (not verified) on 22 September 2026 - 12:20
European Medicines Agency’s privacy statement for the Industry Single Point of Contact (i-SPOC) system
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 22 September 2026 - 11:12
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 3, Status: Authorised
Assessment templates and guidance
Submitted by Anonymous (not verified) on 22 September 2026 - 11:02
Assessment templates and guidance
SME info day - navigating EMA support: From innovation to marketing authorisation, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 6 November 2026, 09:15 (CET) to 6 November 2026, 16:00 (CET)
Submitted by Anonymous (not verified) on 22 September 2026 - 9:49
SME info day - navigating EMA support: From innovation to marketing authorisation, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 6 November 2026, 09:15 (CET) to 6 November 2026, 16:00 (CET)
Human normal immunoglobulins
Submitted by Anonymous (not verified) on 22 September 2026 - 9:32
Human normal immunoglobulins
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 21 September 2026 - 16:34
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 12, Status: Authorised
Regulatory Perspectives on Herbal Medicinal Botanical Drug Product Development - Joint FDA-EMA Workshop: Event agenda
Submitted by Anonymous (not verified) on 21 September 2026 - 16:00
Regulatory Perspectives on Herbal Medicinal Botanical Drug Product Development - Joint FDA-EMA Workshop: Event agenda
Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation: 27/08/2018, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 21 September 2026 - 16:00
Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation: 27/08/2018, Revision: 16, Status: Authorised